Canopy Growth Corp (CGC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Canopy Growth Corp stock (CGC) is currently trading at $0.96. Canopy Growth Corp PS ratio (Price-to-Sales) is 1.52. Analyst consensus price target for CGC is $1.79. WallStSmart rates CGC as Sell.
- CGC PE ratio analysis and historical PE chart
- CGC PS ratio (Price-to-Sales) history and trend
- CGC intrinsic value — DCF, Graham Number, EPV models
- CGC stock price prediction 2025 2026 2027 2028 2029 2030
- CGC fair value vs current price
- CGC insider transactions and insider buying
- Is CGC undervalued or overvalued?
- Canopy Growth Corp financial analysis — revenue, earnings, cash flow
- CGC Piotroski F-Score and Altman Z-Score
- CGC analyst price target and Smart Rating
Canopy Growth Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Canopy Growth Corp (CGC) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Canopy Growth Corp (CGC) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
Paying $1.52 for every $1 of annual revenue
Supporting Valuation Data
Canopy Growth Corp (CGC) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -0.30%, a shrinking business
Company is losing money with a negative profit margin
Very low institutional interest at 12.29%
Small-cap company with higher risk but more growth potential
Canopy Growth Corp (CGC) Detailed Analysis Report
Overall Assessment
This company scores 28/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 9.0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Price/Sales. Valuation metrics including Price/Sales (1.52), Price/Book (0.72) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -0.30%, which may limit upside. Profitability pressure is visible in Return on Equity at -48.50%, Operating Margin at -17.60%, Profit Margin at -117.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -48.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -0.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CGC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CGC's Price-to-Sales ratio of 1.52x trades at a deep discount to its historical average of 106.21x (6th percentile). The current valuation is 100% below its historical high of 709.44x set in Dec 2015, and 246% above its historical low of 0.44x in Jun 2023. Over the past 12 months, the PS ratio has expanded from ~1.3x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for Canopy Growth Corp (CGC) · HEALTHCARE › DRUG MANUFACTURERS - SPECIALTY & GENERIC
The Big Picture
Canopy Growth Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 278M with 0% growth year-over-year. The company is currently unprofitable, posting a -117.3% profit margin.
Key Findings
The company is unprofitable with a -117.3% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -19M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 2.34, so expect amplified moves relative to the broader market.
Sector dynamics: monitor DRUG MANUFACTURERS - SPECIALTY & GENERIC industry trends, competitive moves, and regulatory changes that could impact Canopy Growth Corp.
Bottom Line
Canopy Growth Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(3 last 3 months)
| Insider | Type | Shares |
|---|---|---|
MONGEAU, LUC Director, Chief Executive Officer | Sell | -9,376 |
Data sourced from SEC Form 4 filings
Last updated: 11:29:07 AM
About Canopy Growth Corp(CGC)
NASDAQ
HEALTHCARE
DRUG MANUFACTURERS - SPECIALTY...
USA
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. The company is headquartered in Smiths Falls, Canada.